pixantrone has been researched along with Genetic Diseases, X-Chromosome Linked in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bregni, M; Bugli, A; Mitterer, M; Musuraca, G; Piazza, F; Pinto, A; Spione, M; Zinzani, PL | 1 |
1 other study(ies) available for pixantrone and Genetic Diseases, X-Chromosome Linked
| Article | Year |
|---|---|
Effectiveness and Safety of Pixantrone for the Treatment of Relapsed or Refractory Diffuse Large B-Cell Lymphoma in Every-Day Clinical Practice: The Italian Cohort of the PIXA Registry.
Topics: Adult; Aged; Aged, 80 and over; Cohort Studies; Drug Administration Schedule; Female; Genetic Diseases, X-Linked; Humans; Isoquinolines; Italy; Lymphoma, Large B-Cell, Diffuse; Male; Middle Aged; Neutropenia; Registries; Retrospective Studies; Thrombocytopenia; Topoisomerase II Inhibitors; Treatment Outcome | 2021 |